A novel role of sesamol in inhibiting NF-B-mediated signaling in platelet activation

Journal of Biomedical Science

Volumn 18, Issue 1, 2011, Pages

  Chang, Chao Chien ^a,b   Lu, Wan Jung ^c   Ong, Eng Thiam ^b   Chiang, Cheng Wen ^b   Lin, Song Chow ^c   Huang, Shih Yi ^a   Sheu, Joen Rong ^a,c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CATHAY GENERAL HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

IB; IKK; intracellular Ca2+; platelet activation; protein kinase A; sesamol

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 9 (TETRAHYDRO 2 FURYL)ADENINE; ADENYLATE CYCLASE; COLLAGEN TYPE 1; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FURA 2; GUANYLATE CYCLASE; I KAPPA B ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHOLIPASE C GAMMA2; PROTEIN KINASE C; SESAME SEED OIL; SESAMOL; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG; 1,3 BENZODIOXOLE DERIVATIVE; ANTIOXIDANT; CYCLIC NUCLEOTIDE; PHENOL DERIVATIVE;

ARTICLE; CALCIUM MOBILIZATION; CANCER THERAPY; ENZYME ACTIVATION; FLUORESCENCE; HEMOSTASIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INFLAMMATION; METASTASIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; THROMBOCYTE;

ANTIOXIDANTS; BENZODIOXOLES; BLOOD PLATELETS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HUMANS; NF-KAPPA B; NUCLEOTIDES, CYCLIC; PHENOLS; PLATELET ACTIVATION; SIGNAL TRANSDUCTION;

EID: 83355161461     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-18-93     Document Type: Article

References (27)

1. Metabolic transformation of sesamol and ex vivo effect on 2,2'-azo-bis(2-amidinopropane)dihydrochloride-induced hemolysis. Hou YC, Tsai SY, Liu IL, Yu CP, Chao PD, J Agric Food Chem 2008 56 9636 9640 10.1021/jf801453f 18826229
2. Sesamol exhibits antimutagenic activity against oxygen species mediated mutagenicity. Kaur IP, Saini A, Mutat Res 2000 470 71 76 10986476
3. Global and societal implications of the diabetes epidemic. Zimmet P, Alberti KG, Shaw J, Nature 2001 414 782 787 10.1038/414782a 11742409 (Pubitemid 34000780)
4. Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis. Kapadia GJ, Azuine MA, Tokuda H, Takasaki M, Mukainaka T, Konoshima T, Nishino H, Pharmacol Res 2002 45 499 505 10.1006/phrs.2002.0992 12162952 (Pubitemid 35304500)
5. Development and evaluation of sesamol as an antiaging agent. Sharma S, Kaur IP, Int J Dermatol 2006 45 200 208 10.1111/j.1365-4632.2004.02537.x 16533216 (Pubitemid 43337630)
6. The sesame seed oil constituent, sesamol, induces growth arrest and apoptosis of cancer and cardiovascular cells. Jacklin A, Ratledge C, Welham K, Bilko D, Newton CJ, Ann N Y Acad Sci 2003 1010 374 380 10.1196/annals.1299.068 15033755 (Pubitemid 38265010)
7. Sesamol regulates plasminogen activator gene expression in cultured endothelial cells: a potential effect on the fibrinolytic system. Chen PR, Lee CC, Chang H, Tsai CE, J Nutr Biochem 2005 16 59 64 10.1016/j.jnutbio.2004.07.008 15629242 (Pubitemid 40052718)
8. Sesamol induces nitric oxide release from human umbilical vein endothelial cells. Chen PR, Tsai CE, Chang H, Liu TL, Lee CC, Lipids 2005 40 955 961 10.1007/s11745-005-1456-3 16329468 (Pubitemid 41531945)
9. Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia. Sheu JR, Hung WC, Wu CH, Ma MC, Kan YC, Lin CH, Lin MS, Luk HN, Yen MH, Circulation 1999 99 3056 3062 10368125
10. Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets. Sheu JR, Lee CR, Lin CH, Hsiao G, Ko WC, Chen YC, Yen MH, Thromb Haemost 2000 83 777 784 10823277 (Pubitemid 30248529)
11. Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase. Chang CC, Lu WJ, Chiang CW, Jayakumar T, Ong ET, Hsiao G, Fong TH, Chou DS, Sheu JR, J Nutr Biochem 2010 21 1214 1221 10.1016/j.jnutbio.2009.10.009 20015631
12. New regulators of NF-kappaB in inflammation. Ghosh S, Hayden MS, Nat Rev Immunol 2008 8 837 848 10.1038/nri2423 18927578
13. Demonstration of an activation regulated NF-kappaB/I-kappaBalpha complex in human platelets. Liu F, Morris S, Epps J, Carroll R, Thromb Res 2002 106 199 203 10.1016/S0049-3848(02)00130-5 12297126 (Pubitemid 35248052)
14. Taming platelets with cyclic nucleotides. Schwarz UR, Walter U, Eigenthaler M, Biochem Pharmacol 2001 62 1153 1161 10.1016/S0006-2952(01)00760-2 11705448 (Pubitemid 33055619)
15. Regulation of eukaryotic phosphatidylinositol-specific phospholipase C and phospholipase D. Singer WD, Brown HA, Sternweis PC, Annu Rev Biochem 1997 66 475 509 10.1146/annurev.biochem.66.1.475 9242915 (Pubitemid 27274665)
16. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T, Gerritsen ME, J Biol Chem 1997 272 21096 21103 10.1074/jbc.272.34.21096 9261113 (Pubitemid 27373968)
17. Human megakaryocytes and platelets contain the estrogen receptor beta and androgen receptor (AR): testosterone regulates AR expression. Khetawat G, Faraday N, Nealen ML, Vijayan KV, Bolton E, Noga SJ, Bray PF, Blood 2000 95 2289 2296 10733498 (Pubitemid 30167727)
18. Ligand-specific glucocorticoid receptor activation in human platelets. Moraes LA, Paul-Clark MJ, Rickman A, Flower RJ, Goulding NJ, Perretti M, Blood 2005 106 4167 4175 10.1182/blood-2005-04-1723 16131566 (Pubitemid 41775923)
19. Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARbeta. Ali FY, Davidson SJ, Moraes LA, Traves SL, Paul-Clark M, Bishop-Bailey D, Warner TD, Mitchell JA, FASEB J 2006 20 326 328 16368717 (Pubitemid 46671159)
20. NF-kappaB inhibitors impair platelet activation responses. Malaver E, Romaniuk MA, D'Atri LP, Pozner RG, Negrotto S, Benzadon R, Schattner M, J Thromb Haemost 2009 7 1333 1343 10.1111/j.1538-7836.2009.03492.x 19566544
21. Phospholipase C epsilon: linking second messengers and small GTPases. Bunney TD, Katan M, Trends Cell Biol 2006 16 640 648 10.1016/j.tcb.2006.10.007 17085049 (Pubitemid 44809889)
22. Roles of the C-terminal tyrosine residues of LAT in GPVI-induced platelet activation: insights into the mechanism of PLC gamma 2 activation. Ragab A, Severin S, Gratacap MP, Aguado E, Malissen M, Jandrot-Perrus M, Malissen B, Ragab-Thomas J, Payrastre B, Blood 2007 110 2466 2474 10.1182/blood-2007-02- 075432 17579183 (Pubitemid 47523168)
23. Signaling role for phospholipase C gamma 2 in platelet glycoprotein Ib alpha calcium flux and cytoskeletal reorganization. Involvement of a pathway distinct from FcR gamma chain and Fc gamma RIIA. Mangin P, Yuan Y, Goncalves I, Eckly A, Freund M, Cazenave JP, Gachet C, Jackson SP, Lanza F, J Biol Chem 2003 278 32880 32891 10.1074/jbc.M302333200 12813055 (Pubitemid 37055730)
24. The aging brain, a key target for the future: the protein kinase C involvement. Pascale A, Amadio M, Govoni S, Battaini F, Pharmacol Res 2007 55 560 569 10.1016/j.phrs.2007.04.013 17553691 (Pubitemid 46962312)
25. Structure and function of cyclic nucleotide-dependent protein kinases. Francis SH, Corbin JD, Annu Rev Physiol 1994 56 237 272 10.1146/annurev.ph.56. 030194.001321 8010741 (Pubitemid 24111861)
26. A novel mechanism of G protein-dependent phosphorylation of vasodilator-stimulated phosphoprotein. Profirovic J, Gorovoy M, Niu J, Pavlovic S, Voyno-Yasenetskaya T, J Biol Chem 2005 280 32866 32876 10.1074/jbc.M501361200 16046415 (Pubitemid 41368335)
27. Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase A from an NFkappaB-IkappaB complex. Gambaryan S, Kobsar A, Rukoyatkina N, Herterich S, Geiger J, Smolenski A, Lohmann SM, Walter U, J Biol Chem 2010 285 18352 18363 10.1074/jbc.M109.077602 20356841